Literature DB >> 357037

Should lidocaine be administered routinely to all patients after acute myocardial infarction?

D C Harrison.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 357037     DOI: 10.1161/01.cir.58.4.581

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  10 in total

1.  [Not Available].

Authors:  J Matte; J Rodrigue
Journal:  Can Fam Physician       Date:  1980-05       Impact factor: 3.275

2.  Managing coronaries at home.

Authors: 
Journal:  Br Med J       Date:  1979-06-16

3.  Prophylaxis of primary ventricular fibrillation in acute myocardial infarction. The case against lignocaine.

Authors:  P Kertes; D Hunt
Journal:  Br Heart J       Date:  1984-09

Review 4.  Adverse effects of antiarrhythmic drugs.

Authors:  J B Schwartz; D Keefe; D C Harrison
Journal:  Drugs       Date:  1981-01       Impact factor: 9.546

5.  Prolonged QT interval, atrioventricular block, and torsade de pointes after antiarrhythmic therapy.

Authors:  M T Rothman
Journal:  Br Med J       Date:  1980-03-29

6.  Prophylactic lignocaine and early post-coronary artery occlusion dysrhythmias in anaesthetized greyhounds.

Authors:  R J Marshall; J R Parratt
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

7.  Reappraisal of lignocaine therapy in management of myocardial infarction.

Authors:  B L Pentecost; J V De Giovanni; P Lamb; P J Cadigan; K L Evemy; E J Flint
Journal:  Br Heart J       Date:  1981-01

8.  The effects of lidocaine on the ventricular fibrillation threshold and primary ventricular fibrillation following acute experimental coronary occlusion.

Authors:  B Krämer; H Gülker; W Meesmann
Journal:  Basic Res Cardiol       Date:  1981 Jan-Feb       Impact factor: 17.165

Review 9.  Arrhythmia prophylaxis after acute myocardial infarction: a decade of controversy.

Authors:  D C Harrison
Journal:  Cardiovasc Drugs Ther       Date:  1989-01       Impact factor: 3.727

Review 10.  Risk-benefit stratification as a guide to lidocaine prophylaxis of primary ventricular fibrillation in acute myocardial infarction: an analytic review.

Authors:  L Goldman; W P Batsford
Journal:  Yale J Biol Med       Date:  1979 Sep-Oct
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.